COVID-19
Heart, Lung, & Brain Risks Persist in COVID-19 Survivors

A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk.

vaccines
How COVID-19 and Vaccines Differ in Heart Inflammation

A team of international researchers led by the Max Delbrück Center for Molecular Medicine in.

Long Covid
Long COVID: Extended Paxlovid Treatment Offers Hope

A new case series by UC San Francisco (UCSF) suggests that an extended course of.

rsv vaccine
RSV Vaccine Response in Immunocompromised Adults

According to Johns Hopkins Medicine researchers, people 60 years or older with weakened immunity, primarily.

gut microbiome
Gut Microbiome Predicts Long COVID Risk

In a recent pre-print study published on bioRxiv*, a team of researchers investigated the predictive.

natural protein
COVID-19 & Autoimmune Care Hope: Natural Proteins

Recent research at Umeå University reveals how natural proteins could revolutionize treatments for COVID-19, autoimmune.

COVID-19
FasL Inhibitor Asunercept Speeds COVID-19 Recovery

A new clinical trial demonstrates that an inhibitor of Fas ligand (FasL), also known as.

myocardial scarring
Impact of COVID-19 mRNA Vaccine on Myocardial Scarring

A new study found a greater prevalence of myocardial scarring in young males following COVID-19.

Long-term Cognitive and Psychiatric Issues in COVID-19 Survivors
Long-term Cognitive and Psychiatric Issues in COVID-19 Survivors

A new study published in The Lancet Psychiatry examined whether mental and cognitive symptoms begin.

Mental Health
Mental Health and COVID-19: Unequal Impacts in LA County

A recent study published in the journal PLOS ONE revealed new information about the long-term.